<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02533986</url>
  </required_header>
  <id_info>
    <org_study_id>COGBERRY-BR</org_study_id>
    <nct_id>NCT02533986</nct_id>
  </id_info>
  <brief_title>Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects</brief_title>
  <official_title>Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lund University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to investigate the effect of a 4-weeks intake of berry
      peel powder on fasting and postprandial glucose metabolism and inflammatory markers. The
      berry peel product will be compared with a placebo in a single-blind, cross-over design.
      Furthermore, inflammation-related peripheral blood mononuclear cells (PBMCs) genes
      expression, appetite and cognitive performance will be included as a pilot study.
      Investigators hypothesize that long-term consumption of polyphenols and fibres of berry peel
      will exhibit both direct and indirect actions in healthy overweight subjects by improvement
      of glucose-associated markers as well as ameliorating inflammation. Moreover, above metabolic
      markers will correlated with improvements in inflammation-related PBMCs genes expression,
      subjective appetite and cognitive performance after long-term consumption of berry peel as a
      source of polyphenols.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial blood glucose response after acute intervention</measure>
    <time_frame>-30, 0, 15, 30, 45, 60, 120, and 180 min after challenge meal.</time_frame>
    <description>The capillary blood will be collected for glucose analysis using a glucometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incremental area under curve (iAUC) blood glucose response after long-term intervention</measure>
    <time_frame>4 weeks</time_frame>
    <description>The capillary blood will be collected for glucose analysis using a glucometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial serum insulin response after acute intervention</measure>
    <time_frame>-30, 0, 15, 30, 45, 60, 120, and 180 min.</time_frame>
    <description>The capillary blood will be collected for insulin analysis using commercial ELISA kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under curve (iAUC) serum insulin response after long-term intervention</measure>
    <time_frame>4 weeks</time_frame>
    <description>The capillary blood will be collected for insulin analysis using commercial ELISA kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial subjective appetite rating after acute intervention</measure>
    <time_frame>-30, 0, 15, 30, 45, 60, 120, and 180 min.</time_frame>
    <description>Appetite will be assessed using standard subjective 100mm visual analogue scaled (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under curve (iAUC) subjective appetite rating after long-term intervention</measure>
    <time_frame>4 weeks</time_frame>
    <description>Appetite will be assessed using standard subjective 100mm visual analogue scaled (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial C-reactive protein (CRP) after acute intervention</measure>
    <time_frame>-30, 60, 120, and 180 min.</time_frame>
    <description>The venous blood will be collected for CRP analysis using ELISA commercial kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under curve (iAUC) of C-reactive protein (CRP) after long-term intervention</measure>
    <time_frame>4 weeks</time_frame>
    <description>The venous blood will be collected for inflammatory analysis using ELISA commercial kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial adiponectin after acute intervention</measure>
    <time_frame>-30, 0, 60, 120, and 180 min.</time_frame>
    <description>The venous blood will be collected for adiponectin analysis using ELISA commercial kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial adiponectin after long-term intervention with berry peel</measure>
    <time_frame>4 weeks</time_frame>
    <description>The venous blood will be collected for adiponectin analysis using ELISA commercial kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral blood mononuclear cells (PBMCs) inflammatory genes expression after acute intervention</measure>
    <time_frame>180 min after challenge meal.</time_frame>
    <description>The venous blood samples will be taken for isolation of peripheral blood mononuclear cells (PBMCs). Extracted total RNA will then be used for running quantitative-PCR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral blood mononuclear cells (PBMCs) inflammatory genes expression after long-term intervention</measure>
    <time_frame>-30 min. (Day-28 control); 180 min. (Day-28 control); -30 min. (Day-28 berry); 180 min. (Day-28 berry)</time_frame>
    <description>The venous blood samples will be taken for isolation of peripheral blood mononuclear cells (PBMCs). Extracted total RNA will then be used for running quantitative-PCR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial selective attention after long-term intervention</measure>
    <time_frame>45, 90, and 180 min after challenge meal.</time_frame>
    <description>The selective attention will be assessed using a standardized software (Röd and Grön software) that measures wrong/right decisions and time of reaction when the subjects is faced with a challenging stimulus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial interleukin-6 (IL-6) after acute intervention</measure>
    <time_frame>-30, 60, 120, and 180 min.</time_frame>
    <description>The venous blood will be collected for IL-6 analysis using ELISA commercial kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental area under curve (iAUC) of interleukin-6 (IL-6) after long-term intervention</measure>
    <time_frame>4 weeks</time_frame>
    <description>The venous blood will be collected for IL-6 analysis using ELISA commercial kits</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Control drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dietary supplement: Control drink As control, subjects are asked to consume 150 ml control drink containing equal amount of insoluble fiber (cellulose) and sugar for 28 days. In addition, on days-1 and 28, subjects will receive an acute challenge of placebo drink at our clinical facility. After 30 min. control drink intake, subjects will be given standardized breakfast corresponding to 50 g available carbohydrates.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Berry peel drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary supplement: Berry peel drink Subjects are asked to consume 150 ml experimental drink containing a berry peel fruit powder. In addition, on days-1 and 28, subjects will receive an acute challenge of test drink at our clinical facility. After 30 min. berry drink intake, subjects will be given standardized breakfast corresponding to 50 g available carbohydrates.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Berry peel drink</intervention_name>
    <arm_group_label>Berry peel drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control drink</intervention_name>
    <arm_group_label>Control drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males and females

          -  Signed informed consent

          -  BMI 25-30 kg/m2

          -  Must be able to accept plant-based foods/drinks

        Exclusion Criteria:

          -  Below 18 years or above 40 years

          -  Smoking or using snuff

          -  vegetarian or vegan

          -  Stressed by venous blood sampling or previous experience of being difficult canulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela G Batista, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Lund University; University of Campinas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yoghatama Cindya Zanzer, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Food for Health Science Centre (Medicon Village) - Lund University</name>
      <address>
        <city>Lund</city>
        <state>Skåne</state>
        <zip>221 00</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2015</study_first_submitted>
  <study_first_submitted_qc>August 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2015</study_first_posted>
  <last_update_submitted>February 10, 2016</last_update_submitted>
  <last_update_submitted_qc>February 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lund University</investigator_affiliation>
    <investigator_full_name>Elin Östman</investigator_full_name>
    <investigator_title>Assoc. Prof., PhD</investigator_title>
  </responsible_party>
  <keyword>Berry</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Cognition</keyword>
  <keyword>Polyphenols</keyword>
  <keyword>Appetite</keyword>
  <keyword>Glucose metabolism</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

